Reference
HSA - Health Sciences Authority. Interim update on risk of serious ketoacidosis associated with sodium-glucose cotransporter-2 (SGLT2) inhibitors. Adverse Drug Reaction News 17: No. 2, Sep 2015. Available from: URL: http://www.hsa.gov.sg/content/dam/HSA/HPRG/Safety_Alerts_Product_Recalls_Enforcement/Adverse_Drug_Reaction_News/2015/ADR_News_Sep2015_Vol17_No2.pdf
Rights and permissions
About this article
Cite this article
HSA reviewing risk of ketoacidosis with SGLT2 inhibitors. Reactions Weekly 1574, 5 (2015). https://doi.org/10.1007/s40278-015-1461-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-1461-5